Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Antiviral Research|August 19, 2018
HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI-Resistance associated substitutions in HCV-Infected patients in Mainland ChinaLai Wei, Masao Omata, Young-Suk Lim, et al.
Gastroenterology|June 15, 2016
Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and SofosbuvirChristoph Sarrazin, Hadas Dvory-Sobol, Evguenia S Svarovskaia, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2007
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivativesA Chris Krueger, Darold L Madigan, Brian E Green, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infectionNicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
Hepatology (Baltimore, Md.)|February 7, 2014
All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infectionDavid L Wyles, Maribel Rodriguez-Torres, Eric Lawitz, et al.
JHEP Reports : Innovation in Hepatology|November 6, 2023
Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDVRoberto Mateo, Simin Xu, Alex Shornikov, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivativesA Chris Krueger, Darold L Madigan, David W Beno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2015
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver DiseaseSarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 8, 2017
Identification of hepatitis C virus 2k/1b intergenotypic recombinants in GeorgiaMamuka Zakalashvili, Jaba Zarkua, Michael Weizenegger, et al.
Journal of Hepatology|January 22, 2017
NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcomeStefan Zeuzem, Masashi Mizokami, Stephen Pianko, et al.
Pageof 13